Oncologists and radiologists are holding out hope that Congress will reverse physician fee cuts before the end of the year.
Clinicians weigh BMI, complications, and failed diet and exercise efforts for obesity drugs, but cost, coverage, and ...
NETTER-2 found longer progression-free survival with first-line PRRT, but experts differ on which patients should receive it ...
Treatment with an investigational PDE5 inhibitor significantly slows clinical decline in patients with early AD not taking standard AD medications, but overall trial results are mixed.
A single lower-dose antithrombotic works as well as DAPT after left atrial appendage closure, with less major bleeding. The findings could simplify care.
Excessive nighttime light exposure is associated with cardiac changes, raising questions about bedroom lighting as an ...
Data from a pair of clinical trials show durable improvements in symptoms with the IL-6 receptor inhibitor, but questions ...
Integrated care boards will commission the service within existing budgets, which the King’s Fund says may strain hospitals.
More than half of older patients with non-dialysis CKD stage 4-5 experience pruritus, and about 1 in 4 of those affected ...
In a disease with no agreed standard of care, a trial tested whether an oral add-on could lift blood counts without horse ...
Oncologist Mark A. Lewis, MD, shares how he practices nonjudgmental communication to build trust and encourage shared ...
Familiar layouts, daylight, and green spaces may ease confusion and support independence, experts say, though evidence ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results